• Register
  • Login

Iraqi Postgraduate Medical Journal

  1. Home
  2. Immunohistochemical Expression of Carbonic Anhydrase IX and PAX8 in Renal Cell Carcinoma: A Clinicopathological Correlation Study

Current Issue

By Issue

By Author

By Subject

Author Index

Keyword Index

Copyrights and Licensing

Home

About Journal

Aim and Scope

Editorial Board

Peer Review Process

Copyrights and Licensing

Indexing and Abstracting

Plagiarism Policy

Author's Guide

Article processing charge (APC)

Immunohistochemical Expression of Carbonic Anhydrase IX and PAX8 in Renal Cell Carcinoma: A Clinicopathological Correlation Study

    Authors

    • Hanan Shukur Mahmood
    • Khitam Razzak Kadhim Al-Khafaji

    Department of Pathology, College of Medicine, University of Baghdad, Baghdad, Iraq .

,

Document Type : Research Paper

10.52573/ipmj.2000.182676
  • Article Information
  • References
  • Download
  • Export Citation
  • Statistics
  • Share

Abstract

ABSTRACT:
BACKGROUND:
Renal cell carcinoma is the third most common cancer of genitourinary tract and account for approximately 2-3% of all cancer death. Conventional clear cell carcinoma comprises 75% of all renal cell carcinoma. Immunohistochemical had greatly improved the diagnostic accuracy of renal cell carcinoma.
AIM OF STUDY:
Evaluation of the expression of  PAX-8 & Carbonic anhydrase IX in randomly selected samples from Iraqi patients who have RCC and correlate their expression with the clinicopathological variables.
PATIENTS &METHODS:
This is a retrospective study of 40 patients who were diagnosed to have renal cell carcinoma, CAIX & PAX-8 markers to be applied to the tumor tissue sections.
The results will be evaluated & correlated with the tumor grade, stage & other clinicopathological features.
RESULTS:
The present study showed that twenty five of cases(62.5%) were conventional clear cell RCC while fifteen of cases (37.5%) were non clear cell RCC. Five of cases (12.5%) were grade 1, twenty three of cases (57.5%) were grade 2, ten of cases (25%) were grade 3 and two of cases (5%) were grade 4. Eighteen of cases (45%) were stage I, seven of cases (17.5%) were stage II and fifteen of cases (37.5%) were stage III. The high expression of CAIX was presented in 71.0% of cases while the low expression was presented in 29.0% of cases, While the PAX-8 expression showed 22.5% of cases were score 0, 20% of cases were score 1, 25% of cases were score 2 and 32.5% of cases were score 3.
CONCLUSION:
Higher expression level of CAIX and PAX-8 in clear cell RCC than in non-clear cell type RCC so aid  in differential diagnosis of RCC subtypes. PAX-8 expression was decreases with high nuclear grade while decrease CAIX levels are independently associated with advanced stage. There was no significant correlation between pax-8 &CAIX and clinicopathological variables as age and sex.
 
 

Keywords

  • Carbonic Anhydrase IX
  • PAX8 expression
  • XML
  • PDF 1.34 M
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
References
  1. Eble JN et al. Pathology and genetics of tumors of the urinary system and male genital organs. Lyon: IARC Press; 2004.
  2. Mulders PF et al. Guideline 'Renal cell carcinoma'.  2008;152 :376–80.
  3. Raspollini MR, Montagnani I, Montironi R, et A contemporary series of renal masses with emphasis on recently recognized entities and tumors of low malignant potential: a report based on 624 consecutive tumors from a single tertiary center.  Pathol Res  Pract. 2017;213:804-8.
  4. Chaan S. Ng et al. Renal Cell Carcinoma: Diagnosis, Staging, and Surveillance. American Journal of Roentgenology. 2008;191:1220-32.
  5. Capitanio U, et al. "The epidemiology of renal cell carcinoma". Eur. Urol.2019;75:85–87.
  6. Maher ER. Hereditary Renal cell carcinoma syndromes: diagnosis, surveillance, management. world J Urol.2018;36:1891-98.
  7. Moch H, Humphrey PA, Ulbright TM, Reuter VE. WHO classification of tumors of the urinary system& male genital organs. 4th Lyons,france:IARC; WHO classification of tumor 2016; 8:14-43.
  8. Charles Patrick davis. American Cancer Society. Kidney Cancer (adult)-Renal Cell Carcinoma.2016;10:23-27.
  9. Genega, Musie Ghebremichael and Sabina Signoretti. Carbonic anhydrase IX expression in Renal Neoplasms: Correlation with tumor Type and Grade.2010;134:873-79.
  10. Meaghan L Barr, Lucia B Jilaveanu, et al. PAX-8 expression in renal tumor &distant sites:a useful marker of primary &metastatic renal cell carcinoma.2015;68:12-17.
  11. .Gupta R, Balzer B, Picken M, et al. Diagnostic implications of transcription factor PAX2 protein and transmembrane enzyme complex Carbonic anhydrase IX immunoreactivity in adult renal epithelial neoplasms. Am J Surg pathology.2009;33:241-47.
  1. Atkins M, Regan M, McDermott D, et al .Carbonic anhydrase IX expression predicts outcome of interleukin 2 therapy for renal cancer.Clin Cancer Res.2005;11:3714-21.
  2. Kroeger N, Seligson DB, Klatte T, et al. Clinical, Molecular and genetic correlates of lymphatic spread in clear cell renal cell carcinoma.Eur Urol 2012;61:888-95.
  3. Sangio AR, et al. The use of immunohistochemistry in the diagnostic of metastatic clear cell renal cell carcinoma: a review of PAX-8, PAX-2.hKIM-1,RCCma and CD10.2012;19:128-36 .
  4. Tac ha D,Zhou D, Cheng L. Expression of PAX8 in normal and neoplastic renal tissues: acomprehensive immunohistochemical study App 1 Immunohistochem MoL Morpho.2011;19:293-99.
  5. Laury AR, Perets R, Piao H, et al. A comprehensive analysis of PAX8 expression in human epithelial tumor. AM J surg pathol.2011;35:816-26.
  6. Ashely Cimino-Mathers, Rajni sharma and George J.Netto. Diagnostic use of PAX8, CAIX ,TTF-1 AND TGB in metastatic RCC of the thyroid.Am j Surg pathol. 2011;35:757-61.
  7. Wenjuan Yu, Yuewei Wang, Yanxia Jiang ,Wei Zang and XujunLi. Distinct immunophenotypes and prognostic factors in RCC with sarcomatoid differentiation: a systemic study of 19 immunohistochemical markers in 42 cases. BMC cancer.2017;17:293-99.
    • Article View: 183
    • PDF Download: 91
Iraqi Postgraduate Medical Journal
Volume 22, Issue 3
July 2023
Page 360-367
Files
  • XML
  • PDF 1.34 M
Share
Export Citation
  • RIS
  • EndNote
  • Mendeley
  • BibTeX
  • APA
  • MLA
  • HARVARD
  • VANCOUVER
Statistics
  • Article View: 183
  • PDF Download: 91

APA

Mahmood, H., & Al-Khafaji, K. (2000). Immunohistochemical Expression of Carbonic Anhydrase IX and PAX8 in Renal Cell Carcinoma: A Clinicopathological Correlation Study. Iraqi Postgraduate Medical Journal, 22(3), 360-367. doi: 10.52573/ipmj.2000.182676

MLA

Hanan Shukur Mahmood; Khitam Razzak Kadhim Al-Khafaji. "Immunohistochemical Expression of Carbonic Anhydrase IX and PAX8 in Renal Cell Carcinoma: A Clinicopathological Correlation Study". Iraqi Postgraduate Medical Journal, 22, 3, 2000, 360-367. doi: 10.52573/ipmj.2000.182676

HARVARD

Mahmood, H., Al-Khafaji, K. (2000). 'Immunohistochemical Expression of Carbonic Anhydrase IX and PAX8 in Renal Cell Carcinoma: A Clinicopathological Correlation Study', Iraqi Postgraduate Medical Journal, 22(3), pp. 360-367. doi: 10.52573/ipmj.2000.182676

VANCOUVER

Mahmood, H., Al-Khafaji, K. Immunohistochemical Expression of Carbonic Anhydrase IX and PAX8 in Renal Cell Carcinoma: A Clinicopathological Correlation Study. Iraqi Postgraduate Medical Journal, 2000; 22(3): 360-367. doi: 10.52573/ipmj.2000.182676

  • Home
  • About Journal
  • Editorial Board
  • Submit Manuscript
  • Contact Us
  • Glossary
  • Sitemap

News

This work is licensed under          CC BY 4.0    

 

 

Newsletter Subscription

Subscribe to the journal newsletter and receive the latest news and updates

© Journal Management System. Powered by iJournalPro.com